IRIS
PINI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.482
EU - Europa 8.629
AS - Asia 4.231
SA - Sud America 678
AF - Africa 221
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 11
Totale 23.271
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.345
GB - Regno Unito 1.961
RU - Federazione Russa 1.623
CN - Cina 1.514
IT - Italia 1.428
SG - Singapore 1.227
IE - Irlanda 977
SE - Svezia 614
BR - Brasile 534
UA - Ucraina 527
DE - Germania 490
VN - Vietnam 427
FR - Francia 398
HK - Hong Kong 321
KR - Corea 238
FI - Finlandia 221
IN - India 133
ZA - Sudafrica 126
ES - Italia 83
BD - Bangladesh 79
CA - Canada 74
PL - Polonia 63
BE - Belgio 59
NL - Olanda 51
AR - Argentina 50
PK - Pakistan 40
JP - Giappone 38
TR - Turchia 36
MX - Messico 33
AT - Austria 26
CZ - Repubblica Ceca 24
IR - Iran 24
VE - Venezuela 20
NG - Nigeria 19
CL - Cile 18
EC - Ecuador 18
IQ - Iraq 18
AU - Australia 16
CH - Svizzera 16
KE - Kenya 16
CO - Colombia 14
PH - Filippine 13
AZ - Azerbaigian 12
CI - Costa d'Avorio 12
UZ - Uzbekistan 12
EU - Europa 11
LT - Lituania 11
RO - Romania 11
DZ - Algeria 10
EG - Egitto 10
IL - Israele 10
JO - Giordania 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
ID - Indonesia 9
PE - Perù 9
TN - Tunisia 9
MA - Marocco 8
SA - Arabia Saudita 8
DK - Danimarca 7
TW - Taiwan 7
MY - Malesia 6
PY - Paraguay 6
BO - Bolivia 5
BY - Bielorussia 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
EE - Estonia 5
ET - Etiopia 5
JM - Giamaica 5
BG - Bulgaria 4
LA - Repubblica Popolare Democratica del Laos 4
NP - Nepal 4
OM - Oman 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
GR - Grecia 3
GY - Guiana 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
NI - Nicaragua 2
SI - Slovenia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CM - Camerun 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
Totale 23.255
Salva come PNG Salva come JPEG
Città #
Southend 1.750
Dallas 1.056
Dublin 965
Fairfield 778
Ashburn 690
Singapore 670
Chandler 554
Siena 483
Moscow 461
Jacksonville 428
Santa Clara 408
San Jose 402
Woodbridge 400
Beijing 380
Ann Arbor 349
Seattle 326
Wilmington 321
Houston 308
Hong Kong 299
Hefei 287
Menlo Park 260
Cambridge 246
Seoul 234
Los Angeles 172
Princeton 171
New York 154
The Dalles 146
Nanjing 133
Council Bluffs 130
Milan 123
Johannesburg 120
Ho Chi Minh City 104
Helsinki 96
Munich 94
Lauterbourg 93
Florence 89
Dong Ket 87
Boardman 84
Hanoi 78
Rome 71
San Mateo 67
Málaga 60
Shanghai 60
Buffalo 58
Nanchang 56
San Diego 52
São Paulo 52
Dearborn 42
Fremont 42
Shenyang 41
Orem 40
London 39
Bengaluru 37
Brussels 37
Hebei 34
Turku 34
Warsaw 34
Chicago 33
Redwood City 29
Brooklyn 27
Frankfurt am Main 26
Toronto 26
Tianjin 25
Tokyo 25
Chennai 24
Kunming 24
Redondo Beach 24
Washington 24
Columbus 23
Montreal 23
Stockholm 22
Bagno a Ripoli 21
Changsha 21
Da Nang 21
Porto Alegre 21
Phoenix 20
Abuja 19
Brno 19
Denver 19
Dhaka 19
Nuremberg 19
San Francisco 19
Amsterdam 18
Atlanta 18
Düsseldorf 18
Guangzhou 17
Jiaxing 17
Vienna 17
Belo Horizonte 16
Lappeenranta 16
Manchester 16
Ningbo 16
Hangzhou 15
Izmir 15
Kansas City 15
Paris 15
Rio de Janeiro 15
Zhengzhou 15
Brasília 14
Gdansk 14
Totale 15.645
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 376
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 368
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 364
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 359
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 337
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 327
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 322
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 310
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 308
A new NT4 peptide-based drug delivery system for cancer treatment 304
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 303
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 303
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 302
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 301
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 296
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 295
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 288
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 288
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 287
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 280
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 278
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 276
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 274
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 274
Tumor imaging with tetrabranched neurotensin 268
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 266
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 264
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 264
Branched peptides as bioactive molecules for drug design 262
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 259
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 259
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 257
Branched peptides for tumor diagnosis and therapy 249
Antibacterial peptides and analogues thereof 249
Branched Neurotensin For Tumor Targeting 249
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 244
Bioactive peptides from libraries 243
Branched peptides as targeting agents for tumor imaging and therapy 240
Esculentin-1a-derived peptides promote clearance of pseudomonas aeruginosa internalized in bronchial cells of cystic fibrosis patients and lung cell migration: Biochemical properties and a plausible mode of action 239
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 233
D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions 232
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 231
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 229
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 227
Branched Neurotensin peptides for tumor personalized therapy 226
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 225
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 224
Branched multimeric peptides for tumor diagnosis and therapy 222
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 220
Synthetic peptides in the form of dendrimers become resistant to protease activity 220
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 218
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 218
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 214
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 213
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 211
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 210
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 209
The antimicrobial peptide M33. An example of drug development 209
ANTICORPI E PEPTIDI -I farmaci del XXI secolo- 208
The development of antimicrobial peptides as new antibacterial drugs 207
Branched neurotensin for tumor targeting 206
Tumor selective targeting by branched peptides 202
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 200
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 199
Molecular basis of branched peptides resistance to enzyme proteolysis 199
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 196
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 195
Neurotensin-derived branched peptides and uses thereof 193
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 192
Branched peptides as therapeutics 191
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 187
Phage display and colony filter screening for high-throughput selection of antibody libraries 185
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 182
COMPOSTI ANTI TNF-ALPHA E LORO USI 181
Antimicrobial Peptides towards Clinical Application-A Long History to Be Concluded 175
Synthetic antidotes against snake neurotoxins 175
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 175
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 171
Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa 170
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform 169
The antimicrobial peptide M33. An example of drug development 168
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 165
Branched neurotensin peptides for tumor targeting 163
Tumor imaging with tetrabranched neurotensin 162
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 161
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 160
Dendrimeric peptides for tumor targeting 158
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 157
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 157
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 156
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 155
Peptide sequences, their branched form and use thereof for antimicrobial applications 153
Strategies for the construction and use of peptide and antibody libraries displayed on phages. 153
Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases 144
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 144
Phage display of antibody fragments 144
Synthetic peptides in the form of dendrimers can become resistant to protease activity 142
Synthetic inhibitors of anthrax lethal toxin 139
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 138
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 138
Totale 22.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021206 0 0 0 0 0 0 0 0 0 0 0 206
2021/20221.476 87 157 96 157 93 62 60 78 58 165 171 292
2022/20232.050 114 207 253 279 221 384 50 161 170 85 87 39
2023/20241.572 51 49 130 77 69 440 550 34 8 35 20 109
2024/20253.193 72 140 358 185 390 181 126 200 241 119 331 850
2025/20267.477 565 1.040 846 930 1.470 312 846 261 331 480 257 139
Totale 23.553